TWIST1 and ovarian neoplasm: An interesting experiment has evaluated the function of SFRP5 in drug resistance in ovarian tumor; based on this experiment, epigenetic silencing of SFRP5 results in hyperactivation of Wnt to mediate EMT via TWIST upregulation and increases AKT2 levels in favor of drug resistance in ovarian tumor [150].